MedTrace Logo

Genetic Study of Newly Diagnosed Central Nervous System Tumors in Young Children

NCT00010114 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 83

Last updated 2011-07-20

No results posted yet for this study

Summary

RATIONALE: Genetic studies may help in understanding the genetic processes involved in the development of some types of cancer.

PURPOSE: Genetic study to learn more about genes involved in the development of central nervous system tumors in young children.

Conditions

  • Central Nervous System Embryonal Neoplasm

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Pediatric Brain Tumor Consortium

    lead NETWORK

Principal Investigators

  • Tobey MacDonald, MD · Children's National Research Institute

Eligibility

Max Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-03-31
Primary Completion
2003-03-31
Completion
2003-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00010114 on ClinicalTrials.gov